5866-98-8

Usage

Uses

Used in Agrochemical Industry:
2,6-DICHLORO-3-NITROBENZONITRILE is used as an intermediate in the manufacturing of agrochemicals for its herbicidal and fungicidal properties, helping to control the growth of unwanted plants and fungi in agricultural settings.
Used in Pharmaceutical Industry:
2,6-DICHLORO-3-NITROBENZONITRILE is used as an intermediate in the synthesis of pharmaceutical products, contributing to the development of various medications.
Safety Precautions:
It is crucial to handle 2,6-DICHLORO-3-NITROBENZONITRILE with caution, as it may be harmful if ingested, inhaled, or absorbed through the skin. Proper safety measures and protective equipment should be employed when working with 2,6-DICHLORO-3-NITROBENZONITRILE to minimize potential health risks.

InChI:InChI=1/C7H2Cl2N2O2/c8-5-1-2-6(11(12)13)7(9)4(5)3-10/h1-2H

Upstream product

• 83-38-5 2,6-dichlorobenzaldehyde 
• 5866-97-7 2,6-dichloro-3-nitrobenzaldehyde 
• 124-63-0 methanesulfonyl chloride 
• 89583-94-8 2,6-dichloro-3-nitro-benzaldehyde seqcis-oxime 
• 108-24-7 acetic anhydride 

Downstream Products

• 333458-39-2 6-chloro-2-methylamino-3-nitrobenzonitrile 
• 870486-43-4 6-Chloro-2-ethylamino-3-nitro-benzonitrile 
• 333455-11-1 2-(2,6-Dichlorophenylamino)-6,7-dimethyl-1,8-dihydro-imidazo[4,5-h]isoquinoline-9-one 
• 524695-75-8 2-(3,4-diamino-2-cyanophenyl)-2-methyl-3-oxobutyric acid ethyl ester 
• 500735-24-0 2-[4-cyano-2-(2,6-dichloro-phenylamino)-3-methyl-3H-benzoimidazol-5-yl]-3-oxo-butyric acid methyl ester 
• 333455-23-5 2-(2,6-Dichlorophenylamino)-1,7-dimethyl-9-oxo-1,8-dihydro-imidazo[4,5-h]isoquinolin-6-acetic acid ethyl ester 
• 500735-22-8 2-acetyl-2-[4-cyano-2-(2,6-dichloro-phenylamino)-3-methyl-3H-benzoimidazol-5-yl]-succinic acid diethyl ester 
• 1026035-02-8 2-(4-amino-2-cyano-3-ethylamino-phenyl)-2-methyl-3-oxo-butyric acid ethyl ester 
• 333458-92-7 2-(2,6-dichlorophenylamino)-1,7-dimethyl-9-oxo-1,8-dihydroimidazo[4,5-h]isoquinolin-6-ylacetic acid 
• 333455-20-2 2-(2,6-Dichlorophenylamino)-1,7-dimethyl-6-(2-morpholin-4-yl-2-oxoethyl)-1,8-dihydro-imidazo[4,5-h]isoquinoline-9-one 

Relevant academic research and scientific papers

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

A pharmaceutical composition comprising the compound of Formula Ia, Formula Ib, Formula Ic, or Formula Id, or a pharmaceutically acceptable salt thereof, is set forth. (Formula Ia), (Formula Ib), (Formula Ic), (Formula Id)

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

N-SUBSTUTUTED-6-OXO-1,6-DIHYDROPYRIMIDINE-2-YL DERIVATIVES AS INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula I

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula I.

N-SUBSTITUTED-4-OXO-3,4-DIHYDROPYRIDO[2,3-D]PYRIMIDIN-2-YL DERIVATIVES AS INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth Formula I.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

A compound of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: (I)

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: (I)

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula (I), including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

The compound and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula I